Robert McRae - Semler Scientific Chief Officer
| SMLR Stock | USD 61.78 0.44 0.72% |
Executive
Mr. Robert G. McRae was Chief Operating Officer at Semler Scientific Inc since November 2010. He is a seasoned executive experienced in medical device industry, specifically in growing early stage companies. As Chief Operating Officer, he was responsible for all operational aspects of the Company. From April 2010 until joining the Company, he was the principal consultant of McRae Consulting. From March 2008 to April 2010, he was Vice President, Research and Business Development for Bacchus Vascular, Inc. He was part of the diligence, eventual acquisition, and subsequent integration of Bacchus Vascular into Covidien, Inc. From 2002 to 2007, he held several different positions with VNUS Medical, including heading Manufacturing, Research and Development, and Business Development. Prior to VNUS, he worked at Stryker Endoscopy. Prior to his medical device experience, he held various positions in the United States Navy for a period of six years. He earned a MBA from Santa Clara University and a BS in Mechanical Engineering from San Jose State University. since 2010.
| Age | 55 |
| Tenure | 14 years |
| Professional Marks | MBA |
| Address | 2340-2348 Walsh Avenue, Santa Clara, CA, United States, 95051 |
| Phone | 877 774 4211 |
| Web | https://www.semlerscientific.com |
Semler Scientific Management Efficiency
The company has return on total asset (ROA) of 0.146 % which means that it generated a profit of $0.146 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.2039 %, meaning that it created $0.2039 on every $100 dollars invested by stockholders. Semler Scientific's management efficiency ratios could be used to measure how well Semler Scientific manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Semler Scientific's Return On Tangible Assets are relatively stable compared to the past year. As of 12/20/2024, Return On Assets is likely to grow to 0.28, while Return On Capital Employed is likely to drop 0.29. At this time, Semler Scientific's Return On Assets are relatively stable compared to the past year. As of 12/20/2024, Asset Turnover is likely to grow to 1.18, while Other Assets are likely to drop 0.95.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Debbie Garner | Avita Medical | N/A | |
| Rob Hall | Avita Medical | N/A | |
| Kevin Smith | Inogen Inc | 53 | |
| Philip Corrin | Inogen Inc | N/A | |
| Jessica Ekeberg | Avita Medical | N/A | |
| MBA MD | Inogen Inc | 51 | |
| JD PMP | Avita Medical | N/A | |
| David OToole | Avita Medical | 65 | |
| Terry Bromley | Avita Medical | N/A | |
| Grgoire Ramade | Inogen Inc | 54 | |
| Paul Andreassi | Inogen Inc | N/A | |
| Jennifer Boyer | Inogen Inc | N/A | |
| David Fencil | Avita Medical | N/A | |
| Ron Lagerquist | Avita Medical | N/A | |
| Katie Bush | Avita Medical | N/A | |
| Krishna Jhaveri | Inogen Inc | N/A | |
| Donna Shiroma | Avita Medical | 61 | |
| Adrien Mithalal | Inogen Inc | N/A | |
| Vijay Paliwal | Inogen Inc | N/A | |
| Nicole Kelsey | Avita Medical | N/A | |
Management Performance
Semler Scientific Leadership Team
Elected by the shareholders, the Semler Scientific's board of directors comprises two types of representatives: Semler Scientific inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Semler. The board's role is to monitor Semler Scientific's management team and ensure that shareholders' interests are well served. Semler Scientific's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Semler Scientific's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jennifer Herrington, Chief Officer | ||
| Dennis Rosenberg, Chief Officer | ||
| Shane Reid, Chief Officer | ||
| Herbert Semler, Chairman of the Board, Co-Founder | ||
| Andrew Weinstein, Principal Financial Officer, Senior Vice President - Finance and Accounting | ||
| Douglas MD, President CEO | ||
| Cindy Guinasso, Senior Development | ||
| Robert McRae, Chief Officer | ||
| Renae Cormier, Principal CFO |
Semler Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Semler Scientific a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.2 | ||||
| Return On Asset | 0.15 | ||||
| Profit Margin | 0.27 % | ||||
| Operating Margin | 0.37 % | ||||
| Current Valuation | 591.47 M | ||||
| Shares Outstanding | 9.27 M | ||||
| Shares Owned By Insiders | 17.21 % | ||||
| Shares Owned By Institutions | 43.48 % | ||||
| Number Of Shares Shorted | 1.28 M | ||||
| Price To Earning | 16.64 X |
Pair Trading with Semler Scientific
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Semler Scientific position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Semler Scientific will appreciate offsetting losses from the drop in the long position's value.Moving together with Semler Stock
Moving against Semler Stock
| 0.88 | DRIO | DarioHealth Corp | PairCorr |
| 0.78 | EDAP | EDAP TMS SA | PairCorr |
| 0.73 | VERO | Venus Concept | PairCorr |
| 0.61 | CI | Cigna Corp | PairCorr |
| 0.36 | VTAK | Catheter Precision | PairCorr |
The ability to find closely correlated positions to Semler Scientific could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Semler Scientific when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Semler Scientific - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Semler Scientific to buy it.
The correlation of Semler Scientific is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Semler Scientific moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Semler Scientific moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Semler Scientific can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Semler Stock Analysis
When running Semler Scientific's price analysis, check to measure Semler Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Semler Scientific is operating at the current time. Most of Semler Scientific's value examination focuses on studying past and present price action to predict the probability of Semler Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Semler Scientific's price. Additionally, you may evaluate how the addition of Semler Scientific to your portfolios can decrease your overall portfolio volatility.